| Literature DB >> 32655667 |
Zhi-Hui Zhao1, Yi Zhou2, Wei-Hong Li1, Zhao-Hui Tang1, Ting-Wei Xia1.
Abstract
OBJECTIVE: The efficacy of auricular acupressure in patients with hypertension and insomnia is controversial. This systematic review aims to explore the effectiveness of auricular acupressure in reducing blood pressure and improving sleep in this population.Entities:
Year: 2020 PMID: 32655667 PMCID: PMC7317612 DOI: 10.1155/2020/7279486
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Figure 1Flow chart of selection process.
Characteristics of included studies.
| Author, year | Participants | No. (T/C) | Main acupoints | Intervention time (days) | Control type | Outcome measures |
|---|---|---|---|---|---|---|
| Shang, 2015 | Middle aged and elderly patients with hypertension and insomnia | 148/150 | Jiangyagou, Shenmen, heart, endocrine, Jiaogan, and Pizhixia | 28 | I | ①②③ |
| Lin, 2018 | Young and middle-aged patients with hypertension and insomnia | 25/25 | Heart, kidney, and liver | 6 | II | ①⑥ |
| Zhang, 2018 | Patients with hypertension and insomnia | 36/36 | Jiangyagou, Shenmen, heart, brain, kidney, liver, and spleen | 18 | II | ⑤ |
| Zhang, 2019 | Patients with hypertension and insomnia | 43/43 | Jiangyagou, Shenmen, Sanjiao, Jiaogan, and Pizhixia | 15 | II | ②③⑦ |
| Gao, 2015 | Patients with hypertension and insomnia | 30/30 | Heart, kidney, brain, Shenmen, and Jiangyagou | 15 | I | ⑦ |
| Wang, 2018 | Patients with grades 1 and 2 hypertension and insomnia | 40/40 | Liver, kidney, Jiaogan, Shenmen, heart, and Jiangyagou | 28 | I | ①②③ |
| Wang, 2016 | Patients with grade 1 hypertension and insomnia | 30/30 | Pizhixia, Jiaogan, Shenmen, and Jiangyagou | 14 | II | ①②③⑥ |
| Zhu, 2017 | Patients with hypertension and insomnia | 72/72 | Jiaogan, Shenmen, Jiangyagou, heart, liver, and kidney | 28 | I | ①②③ |
| Li, 2017 | Patients with grades 1 and 2 hypertension and insomnia | 32/33 | Jiaogan, Shenmen, Pizhixia, heart, and liver | 14 | I | ①②③ |
| Xiao, 2014 | Patients with hypertension and insomnia | 25/25 | Jiaogan, Shenmen, Pizhixia, heart, and endocrine | 15 | III | ②③④ |
| Liu, 2018 | Patients with hypertension and insomnia | 60/60 | Heart, Jiaogan, Shenmen, and Jiangyagou | 10 | I | ① |
| Qian, 2019 | Elderly patients with hypertension and insomnia | 30/30 | Spleen, liver, Shenmen, heart | 14 | II | ① |
| Liu, 2019 | Elderly patients with hypertension and insomnia | 30/30 | Heart, Jiaogan, Shenmen, endocrine, Chuiqian, and minor points | 10 | I | ⑤ |
| Ruan, 2019 | Patients with hypertension and insomnia | 38/38 | Heart, liver, kidney, spleen, Jiangyagou | 30 | II | ①②③ |
| Bao, 2019 | Patients with hypertension and insomnia | 52/52 | Heart, liver, kidney, spleen, and Jiangyagou | Unclear | I | ①②③ |
| Zhang, 2016 | Patients with hypertension and insomnia | 40/40 | Heart, liver, kidney, spleen, and Jiangyagou | 25 | III | ②③④ |
| Qiao, 2014 | Patients with grade 1 hypertension and insomnia | 30/30 | Liver, kidney, Pizhixia, Jiangyagou, endocrine, and Shenmen | 15 | II | ⑧④ |
| Zhang, 2019 | Patients with hypertension and insomnia | 80/80 | Jiaogan, Shenmen, Jiangyagou, and heart | 15 | II | ⑥ |
①: PSQI; ②: SBP; ③: DBP; ④: the diagnostic and therapeutic criteria for TCM syndromes; ⑤: Self-Made Sleep Status Self-Assessment Scale; ⑥: guidelines for TCM (new drug) clinical research; ⑦: Sleep Status Self-Assessment Scale. I: routine nursing; II: conventional Western medicine; III: no intervention.
Figure 2Risk of bias graph.
Figure 3Risk of bias summary.
Figure 4Forest plot of the comparison between auricular acupressure and the control group for the outcome systolic blood pressure.
Subgroup analyses based on various criteria for systolic blood pressure.
| Subgroup |
| MD (95% CI) | Heterogeneity (%) |
|
|---|---|---|---|---|
| Total sample size | ||||
| >80 | 6 | −16.33 [−19.45, −13.22] | 79 |
|
| ≤80 | 4 | −13.85 [−19.67, −8.04] | 96 |
|
|
| ||||
| Intervention time | ||||
| ≤15 days | 4 | −11.62 [−18.75, −4.50] | 95 |
|
| >15 days | 5 | −16.52 [−20.81, −12.22] | 93 |
|
|
| ||||
| Control type | ||||
| AP + AHDs vs. AHDs | 7 | −14.42 [−19.16, −9.68] | 94 |
|
| AP vs. no intervention | 2 | −19.10 [−21.06, −17.14] | 28 |
|
AP: auricular acupressure; AHDs: antihypertensive drugs.
Figure 5Forest plot of the comparison between auricular acupressure and the control group for the outcome diastolic blood pressure.
Subgroup analyses based on various criteria for diastolic blood pressure.
| Subgroup |
| MD (95% CI) | Heterogeneity (%) |
|
|---|---|---|---|---|
| Total sample size | ||||
| ≤80 | 6 | −7.31 [−10.82, −3.79] | 94 |
|
| >80 | 4 | −10.21 [−16.56, −3.85] | 96 |
|
|
| ||||
| Intervention time | ||||
| ≤15 days | 4 | −6.54 [−10.37, −2.70] | 86 |
|
| >15 days | 5 | −8.04 [−12.14, −3.94] | 96 |
|
|
| ||||
| Control type | ||||
| AP + AHDs vs. AHDs | 7 | −8.08 [−11.82, −4.33] | 95 |
|
| AP vs. no intervention | 2 | −9.72 [−11.04, −8.40] | 0 |
|
AP: Auricular acupressure; AHDs: Antihypertensive drugs.
Figure 6Forest plot of the comparison between the auricular acupressure and the control group for the outcome PSQI.
Subgroup analyses based on various criteria for PSQI.
| Subgroup |
| MD (95% CI) | Heterogeneity (%) |
|
|---|---|---|---|---|
| Total sample size | ||||
| ≤80 | 4 | −2.96 [−2.96, −2.09] | 0 |
|
| >80 | 6 | −2.26 [−6.42, −1.89] | 99 |
|
|
| ||||
| Intervention time | ||||
| ≤15 days | 5 | −4.16 [−6.20, −2.13] | 93 |
|
| >15 days | 4 | −0.12 [−12.14, −4.32] | 99 |
|
|
| ||||
| Control type | ||||
| AP + AHDs vs. AHDs | 6 | −0.71 [−3.86, −2.43] | 99 |
|
| AP vs. no intervention | 3 | −4.67 [−7.09, −2.25] | 84 |
|
AP: auricular acupressure; RN: routine nursing.
Figure 7Forest plot of the comparison between auricular acupressure and the control group for the efficiency rate of the diagnostic and therapeutic criteria for TCM syndromes.
Figure 8Forest plot of the comparison between auricular acupressure and the control group for the efficiency rate of the guidelines for TCM (new drug) clinical research.
Figure 9Funnel plot of trials comparing systolic blood pressure.